Vironova
Desconocido
MAD-CoV 2: Modern approaches for developing antivirals against SARS CoV 2
VIRONOVA AB
participó en un
H2020:
H2020-JTI-IMI2-2020-21-single-stage
The SARS-CoV-2 pandemic has become an unprecedented burden to public health, our civil societies and the global economy. To provide frontlin...
2020-08-11 - 2025-07-31 | Financiado
2020-08-11 - 2025-07-31 | Financiado
FLUCURE: Development of novel antiviral drugs against Influenza
VIRONOVA AB
tramitó un
FP7:
Influenza viruses cause a highly contagious respiratory disease in both humans and animals. Typically, influenza spreads worldwide in season...
Financiado
Financiado
FLUDRUGSTRATEGY: Combating influenza using a novel drug strategy
VIRONOVA AB
tramitó un
FP7:
Objective: To find and produce novel target compounds against the influenza virus. Influenza A capsid protein is the target since it does no...
Financiado
Financiado
* No se disponen de datos de la empresa actual.